Merck Joins $120M Virginia Pharmaceutical Investment

VIPC executed a Memorandum of Understanding involving AstraZeneca, Eli Lilly, and Merck to support a $120M industry investment in the Virginia Center for Advanced Pharmaceutical Manufacturing. The minutes do not specify an individual amount or term for Merck.

Document date · December 2, 2025

Track Virginia Innovation Partnership Authority (VIPA) contracts

Get alerts when new contracts are awarded or existing ones approach renewal at Virginia Innovation Partnership Authority (VIPA).

Get started free

Create a free account · no credit card

Work in government? Get Civic IQ free

Scope & details

The full contract record, as filed.

Contract amount

$120M industry investment (aggregate investment referenced for AstraZeneca, Eli Lilly, and Merck)

Contract type

OTHER

Document type

Minutes

Source document

Virginia Innovation Partnership Authority Minutes Joint Board Meeting December 2, 2025

Related contracts

Other contracts from MERCK.

View all →

Kit Carson County Department of Public Health Minutes 2026-09-23

APPROVED

Kit Carson County, Colorado$1,027.36Sep 23, 2026

Town of Millsboro Agenda Town Council Meeting and Executive Session 2026-09-08

DISCUSSED

Town of Millsboro, DelawareSep 8, 2026

City of Denton Animal Shelter Advisory Committee Agenda Packet 2026-08-12

DISCUSSED

City of Denton, TexasAug 12, 2026

Upper Gwynedd Township Minutes Planning Commission Meeting 2026-08-12

Upper Gwynedd Township Minutes Business Meeting August 10, 2026

APPROVED

Town of Upper Gwynedd, PennsylvaniaAug 10, 2026

Frequently asked questions

Common questions about this contract, answered from the record.

Who was awarded the government contract by Virginia Innovation Partnership Authority (VIPA)?

MERCK was awarded this government contract by Virginia Innovation Partnership Authority (VIPA), as recorded on December 2, 2025. The contract value is $120M industry investment (aggregate investment referenced for AstraZeneca, Eli Lilly, and Merck).

How much is the MERCK contract with Virginia Innovation Partnership Authority (VIPA) worth?

The MERCK contract with Virginia Innovation Partnership Authority (VIPA) is valued at $120M industry investment (aggregate investment referenced for AstraZeneca, Eli Lilly, and Merck).

What type of contract is this?

This is a government contract, documented as a minutes record.

Where was this contract approved?

This contract appears in Virginia Innovation Partnership Authority Minutes Joint Board Meeting December 2, 2025 (Minutes), dated December 2, 2025 from Virginia Innovation Partnership Authority (VIPA). Civic IQ extracts contract records directly from agency meeting documents and solicitations.

What other contracts does MERCK hold?

MERCK may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.

View MERCK's profile

What is Virginia Innovation Partnership Authority (VIPA) currently buying?

Explore Virginia Innovation Partnership Authority (VIPA)'s vendors, signed contracts, and active RFPs on their Civic IQ agency profile.

View Virginia Innovation Partnership Authority (VIPA)'s profile